Matthew Stephen Shute, PA

Matthew Shute practices at St Josephs Medical in Fayetteville, New York.

Matthew Shute's NPI, 1639198526, was assigned on July 19, 2006. Matthew Shute holds New York license 011106.

Matthew Shute's primary practice is St Josephs Medical, at 4104 Medical Center Dr, Fayetteville, NY 13066 in Onondaga County. The practice phone is (315) 452-2828.

Matthew Shute's primary practice is St Josephs Medical in Fayetteville, New York. Matthew Shute is also affiliated with St. Joseph's Health Hospital. The medical group on file is St. Joseph's Physicians Primary Care Center - OB/GYN. Dmand AI also links Matthew Shute to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Shute practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Matthew Shute's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Matthew Shute is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Matthew Shute is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, alzheimer's disease, bronchitis, chronic obstructive pulmonary disease (COPD), chronic sinusitis, conjunctivitis and contact dermatitis among the conditions Matthew Shute treats.

CMS data shows 820 Medicare services from Matthew Shute across 16 procedure codes in 2024, for 318 Medicare patients. Medicare paid $29,223 for them. Every service was in an office.

CMS counts 318 Medicare patients who saw Matthew Shute in 2024. The largest group is 65 to 74, with 141 patients. 66% of them have high blood pressure, and 58% have high cholesterol. 12% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Shute's median patient age at 56, with 61% women.

In 2024, Matthew Shute wrote 2,002 Medicare Part D claims for 457 patients. 87% of them were for generic drugs. CMS names the drug for 1,539 of them, across 50 drugs with 11 or more claims each, at $111,859 in total drug cost.

Matthew Shute accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Shute as offering telehealth.

CMS Open Payments shows 80 general payments to Matthew Shute from 24 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $148.